GLP-3 / Tesa / Cagri
SKU：glp-3-tesa-cagri
Price：USD 155.00
Product information
This 17.5 mg blend contains 10 mg GLP-3, 5 mg Tesamorelin and 2.5 mg Cagri. It combines a triple-receptor incretin compound, a GHRH analog and an amylin analog in one vial. The ingredients are characterized separately in research; the combined formulation has not been characterized as a single entity, and no combined clinical effect is established.
Product specifications
- Components
- GLP-3 + Tesamorelin + Cagri
- Content
- 17.5 mg per vial (10 mg + 5 mg + 2.5 mg)
- Pathways
- Incretin · GHRH axis · amylin
- Form
- Lyophilized powder blend
- Purity
- ≥99% by HPLC
- Appearance
- White to off-white powder
- Solubility
- Water-soluble
- Storage
- -20°C, protected from light
- Classification
- Research use only
- Label amount
- 10mg / 5mg / 2.5mg
Analysis report
No test report for the selected option
Match the product, option and lot in the report.
Research information
Read the full GLP-3 / Tesa / Cagri research monograph
Research overview
This 17.5 mg blend contains 10 mg GLP-3, 5 mg Tesamorelin and 2.5 mg Cagri. It combines a triple-receptor incretin compound, a GHRH analog and an amylin analog in one vial. The ingredients are characterized separately in research; the combined formulation has not been characterized as a single entity, and no combined clinical effect is established.